Therapy News and Research

RSS

Chemicals in curry and onions may help prevent colon cancer

A small but informative clinical trial by Johns Hopkins investigators shows that a pill combining chemicals found in turmeric, a spice used in curries, and onions reduces both the size and number of precancerous lesions in the human intestinal tract.

1 Aug 2006

Knee bone marrow lesions may be hereditary

Bone marrow lesions in the knee, a cause of pain in patients with knee osteoarthritis, may be hereditary.

1 Aug 2006

COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the most popular treatment for arthritis - despite their association with gastrointestinal (GI) complications, including bleeding ulcers and death.

27 Jul 2006

1 in 5 youth with diabetes has heart risk

With the epidemic of obesity in the United States leading to a greater incidence of diabetes among youth, a new study highlights why Americans cannot afford to ignore this dangerous trend: One in five youth with diabetes has already developed two or more additional risk factors for premature heart disease.

27 Jul 2006

Promising therapy for Lou Gehrig's disease delivers antisense drug directly to nervous system

Researchers have designed and tested a molecular therapy in animals that they hope will be a major development in the fight to treat amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.

27 Jul 2006

Nitric oxide reduces lung disease in premature, very-low-birth-weight infants

Delivering nitric oxide to the lungs of premature, very-low-birth-weight infants during their second week of life improves their chances of surviving without chronic lung disease, according to a national study of nearly 600 babies.

26 Jul 2006

Heat treatment may zap cancer cells

Scientists believe they have discovered a clue as to why so many men with testicular cancer survive against the odds.

26 Jul 2006

Periodic 'deep inflation' helps prevent ventilator-induced lung injury

Ventilation therapy burst into the public consciousness more than 60 years ago with the "iron lung" and the polio epidemic.

26 Jul 2006

Understanding postpartum depression critical to improving care for mothers and infants

Physicians should screen mothers for postpartum depression regularly for at least a year following childbirth to better identify women who develop symptoms throughout the year and those whose depression persists, University of Rochester Medical Center researchers say.

26 Jul 2006

Combining chemotherapy with radiation therapy after the surgical removal of cancer in the pancreas improves survival

Patients with pancreatic cancer, a historically difficult-to-treat cancer with poor survival rates, may benefit from treatments studied in an international, multi-center research trial.

26 Jul 2006

Heat sensitivity may make testicular cancer cells more susceptible to standard treatments and die off more readily

Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers.

26 Jul 2006

Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain

Chronic widespread pain, a common medical condition, can be difficult to treat and is often associated with fatigue, poor sleep and depression.

26 Jul 2006

Remicade receives European approval for treatment of psoriatic arthritis

Schering-Plough Corporation today announced that the European Commission has approved the use of Remicade (infliximab) as monotherapy in the treatment of active and progressive psoriatic arthritis (PsA) in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated.

26 Jul 2006

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE has today issued guidance for the use of the targeted biological therapies, Enbrel (etanercept) and Raptiva (efalizumab), to treat adult patients with severe plaque psoriasis.

26 Jul 2006

Cancer Research Technology announce collaboration with Hammersmith Hospital to develop high intensity focused ultrasound for the treatment of cancer

Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, today announce that they have entered into an agreement with Hammersmith Hospitals NHS Trust (London, UK) to develop Phased Array High-Intensity Focused Ultrasound (HIFU) for the treatment of cancer.

26 Jul 2006

Therapy News and Research

Chemicals in curry and onions may help prevent colon cancer

Knee bone marrow lesions may be hereditary

COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals

1 in 5 youth with diabetes has heart risk

Promising therapy for Lou Gehrig's disease delivers antisense drug directly to nervous system

Nitric oxide reduces lung disease in premature, very-low-birth-weight infants

Heat treatment may zap cancer cells

Periodic 'deep inflation' helps prevent ventilator-induced lung injury

Understanding postpartum depression critical to improving care for mothers and infants

Combining chemotherapy with radiation therapy after the surgical removal of cancer in the pancreas improves survival

Heat sensitivity may make testicular cancer cells more susceptible to standard treatments and die off more readily

Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain

Remicade receives European approval for treatment of psoriatic arthritis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

Cancer Research Technology announce collaboration with Hammersmith Hospital to develop high intensity focused ultrasound for the treatment of cancer

Insufficient evidence exists to support the use of complementary and alternative therapies to relieve menopause

Estrogen and testosterone combination to treat menopause may increase risk of breast cancer

Is there improvement of 'vascular depression' after carotid artery stenting?

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

Distribution of more than 18 million malaria bednets in Africa

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News